Trulieve Cannabis Corp. (TCNNF) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Trulieve Cannabis Corp. (TCNNF) Healthcare & Pipeline Overview

Trulieve Cannabis Corp. is a vertically integrated medical cannabis company focused on cultivation, production, and retail distribution through its branded dispensaries, primarily in Florida and expanding to other key states. With a wide range of cannabis products, Trulieve aims to serve diverse patient needs in the rapidly growing medical cannabis market.

What Is the Investment Thesis for TCNNF?

Trulieve Cannabis Corp. presents a notable research candidate within the expanding medical cannabis market. The company's strong foothold in Florida, demonstrated by its extensive dispensary network and vertically integrated operations, provides a solid foundation for revenue generation. Trulieve's gross margin of 57.7% indicates efficient operations and pricing power. Growth catalysts include the ongoing expansion into new states and the potential for further legalization of cannabis at the state and federal levels. However, investors should be aware of the risks associated with the cannabis industry, including regulatory uncertainty and intense competition. The company's negative P/E ratio of -10.48 and profit margin of -9.9% highlight the need for improved profitability. Successful execution of expansion strategies and effective cost management will be critical for Trulieve to achieve sustainable profitability and deliver long-term value to shareholders.

Based on FMP financials and quantitative analysis

TCNNF Key Highlights

Trulieve Cannabis Corp. operates 162 dispensaries as of March 16, 2022, demonstrating a significant retail presence.

• The company has a strong presence in Florida, with 113 dispensaries, indicating a dominant market share in the state.
• Trulieve's gross margin of 57.7% reflects efficient operations and pricing power in the cannabis market.
• The company cultivates and produces its products in-house, ensuring quality control and consistency.
• Trulieve's product portfolio includes a wide range of cannabis products, catering to diverse patient preferences and needs.

Who Are TCNNF's Competitors?

TCNNF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are TCNNF's Key Strengths?

Strong market position in Florida.

• Vertically integrated operations.
• Extensive dispensary network.
• Wide range of cannabis products.

What Are TCNNF's Weaknesses?

Negative P/E ratio and profit margin.

• Reliance on the Florida market.
• Exposure to regulatory risks.
• Intense competition in the cannabis industry.

What Could Drive TCNNF Stock Higher?

Potential for further legalization of cannabis at the state and federal levels.

• Expansion into new states and markets.
• Product innovation and development.
• Strategic acquisitions to expand market share.
• Increased retail footprint through new dispensary openings.

What Are the Key Risks for TCNNF?

Financial-distress signal — its Altman Z-Score of 1.22 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-6.8%) — the business is not currently generating profit on shareholder capital.
• Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.
• Evolving regulations and uncertainty surrounding cannabis legalization.
• Intense competition in the cannabis industry.
• Price volatility and fluctuations in cannabis prices.
• Negative public perception and social stigma associated with cannabis.
• Limited access to capital and financing options.

What Are the Growth Opportunities for TCNNF?

• Expansion into New Markets: Trulieve has the opportunity to expand its operations into new states that have legalized medical or recreational cannabis. By replicating its successful vertically integrated model in Florida, Trulieve can establish a strong presence in these emerging markets. The timeline for expansion will depend on the regulatory environment in each state, but the potential market size is significant, with each new state representing a multi-million dollar revenue opportunity.
• Product Innovation and Development: Trulieve can drive growth by developing new and innovative cannabis products that cater to evolving consumer preferences. This includes exploring new formulations, delivery methods, and therapeutic applications. The market for cannabis-infused products is rapidly expanding, and Trulieve can capitalize on this trend by introducing new products that meet the needs of different consumer segments. The timeline for product development is typically 6-12 months, and the potential market size is substantial, with new products driving incremental revenue growth.
• Strategic Acquisitions: Trulieve can pursue strategic acquisitions to expand its market share and geographic reach. By acquiring smaller cannabis companies or dispensaries, Trulieve can quickly gain access to new markets and customer bases. The timeline for acquisitions will depend on the availability of suitable targets and the regulatory approval process, but the potential benefits include increased revenue, market share, and operational synergies. The market size for acquisitions is significant, with numerous opportunities to consolidate the fragmented cannabis industry.
• Increased Retail Footprint: Trulieve can continue to expand its network of Trulieve-branded dispensaries in existing and new markets. By increasing its retail footprint, Trulieve can improve access to its products and enhance its brand visibility. The timeline for dispensary expansion will depend on the regulatory environment and the availability of suitable locations, but the potential benefits include increased revenue and customer loyalty. The market size for retail cannabis is substantial, with dispensaries serving as a key distribution channel for cannabis products.
• Advocacy and Lobbying Efforts: Trulieve can actively engage in advocacy and lobbying efforts to promote the legalization of cannabis at the state and federal levels. By supporting pro-cannabis legislation, Trulieve can help to create a more favorable regulatory environment for its business. The timeline for legislative changes is uncertain, but the potential benefits include increased market access and reduced regulatory burdens. The market size for legal cannabis is enormous, and Trulieve can play a key role in shaping the future of the industry.

What Are TCNNF's Competitive Advantages?

• Strong brand recognition and customer loyalty in Florida.
• Vertically integrated operations, providing control over the supply chain.
• Extensive network of Trulieve-branded dispensaries.
• Proprietary cultivation and processing techniques.

What Does TCNNF Do?

Trulieve Cannabis Corp. was founded with the mission to provide safe, reliable, and high-quality medical cannabis products to patients. Originally known as Schyan Exploration Inc./Exploration Schyan Inc., the company rebranded to Trulieve Cannabis Corp. in September 2018, marking its strategic shift towards the cannabis industry. Headquartered in Quincy, Florida, Trulieve has established itself as a dominant player in the state's medical cannabis market. The company cultivates and produces its products in-house, ensuring quality control and consistency. Trulieve's product portfolio includes flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays, catering to a wide range of patient preferences and needs. These products are sold under various brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One. Trulieve distributes its products through its extensive network of Trulieve-branded dispensaries, numbering 162 as of March 16, 2022, with a significant presence in Florida (113 dispensaries) and expanding operations in Pennsylvania (19 affiliated dispensaries), Arizona (17 dispensaries), California (5 dispensaries), Maryland (3 dispensaries), Massachusetts (2 dispensaries), West Virginia (2 dispensaries), and Connecticut (1 dispensary). The company also operates cultivation and processing facilities in multiple states, including Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia, further solidifying its vertically integrated business model.

What Products and Services Does TCNNF Offer?

• Cultivates and produces medical cannabis products in-house.
• Distributes cannabis products through Trulieve-branded dispensaries.
• Offers home delivery services for medical cannabis patients.
• Sells a variety of cannabis products, including flower, edibles, and concentrates.
• Operates cultivation and processing facilities in multiple states.
• Focuses on providing safe, reliable, and high-quality medical cannabis products.

How Does TCNNF Make Money?

• Vertically integrated operations, from cultivation to retail distribution.
• Revenue generation through sales of cannabis products at dispensaries and via home delivery.
• Focus on building a strong brand presence and customer loyalty.
• Expansion into new markets through strategic acquisitions and organic growth.

What Industry Does TCNNF Operate In?

The medical cannabis industry is experiencing rapid growth, driven by increasing acceptance of cannabis for therapeutic purposes and the legalization of medical cannabis in numerous states. Companies like Trulieve are capitalizing on this trend by establishing vertically integrated operations and expanding their retail footprint. The competitive landscape includes other multi-state operators (MSOs) as well as smaller, regional players. The industry is subject to evolving regulations and intense competition, requiring companies to adapt quickly and differentiate themselves through product quality, branding, and customer service. The market is projected to continue its growth trajectory, fueled by increasing patient adoption and potential further legalization efforts.

Who Are TCNNF's Key Customers?

• Medical cannabis patients seeking relief from various medical conditions.
• Adults seeking cannabis for recreational use (in states where it is legal).
• Wholesale customers (other dispensaries and retailers).

The most recent 11 insider filings for Trulieve Cannabis Corp. break down as 5 sales and 6 purchases. On net that is roughly 791K shares acquired (about $2.9M) — insiders putting money in tends to read as conviction.

Quarterly Financial Performance: Trulieve Cannabis Corp.

Revenue for Trulieve Cannabis Corp. came in at $271.0M during Q2 FY2026, a 4.2% contraction versus the preceding quarter. The company recorded a net loss of $406.0M, with diluted EPS of $-2.11. Revenue has contracted over three consecutive quarters, which investors in this mid-cap Healthcare stock should monitor closely. Across the four most recent quarters, TCNNF averaged $-0.62 in diluted EPS.

TCNNF Valuation & Market Position

With a $2.32B market cap, Trulieve Cannabis Corp. sits in the mid-cap segment of the market. Relative to its peer group, TCNNF's quantitative score of 50/100 is roughly in line with the peer average of 58/100.

Return on equity for Trulieve Cannabis Corp. stands at -6.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.9%, showing how much profit it generates from its asset base. Its free cash flow yield is 13.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.26 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -4.4%, the inverse of the P/E and a quick read on earnings relative to price.

Trulieve Cannabis Corp.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.22 places it in the distress zone, a signal of elevated financial risk.

Trulieve Cannabis Corp. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 510.2% below estimates on average.

Company Profile

Trulieve Cannabis Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Tallahassee, US. The company is led by CEO Kimberly Rivers. TCNNF has traded publicly since 2018.

TCNNF Financials

TCNNF Latest News

TCNNF Analyst Consensus

TCNNF MoonshotScore

Trulieve Cannabis Corp. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources